Methylphenylsulfide

Methylphenylsulfide

SCHEMBL8949917

CSc1ccccc1.O=[PH](O)CP(=O)(O)O

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.35
KMT2A Q03164 5/20 0.35
MEN1 O00255 4/20 0.35
MAPT P10636 2/20 0.35
POLB P06746 2/20 0.35
TP53 P04637 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HPGD P15428 2/20 0.35
PTGS2 P35354 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL8949748 0.80 LMNA (0.42) KMT2AMEN1POLBNPC1RAB9A
Methylphenylsulfide SCHEMBL8949908 0.77 MEN1 (0.41) KCNH2KMT2AMEN1MAPTPOLB
SCHEMBL8949897 0.76 TSHR (0.48) KMT2AMEN1HSD17B10ALDH1A1CYP1A2
Ethane SCHEMBL8949916 0.72 KDM4E (0.35) MAPK1HSD17B10
SCHEMBL7597199 0.72
Methylphenylsulfide SCHEMBL4382711 0.72 MAPT (0.50) KMT2AMEN1MAPTPOLBTP53
Methylphenylsulfide SCHEMBL4382713 0.72 MAPT (0.50) KMT2AMEN1MAPTPOLBTP53
Methylamine SCHEMBL9161547 0.70 LAP3 (0.35) MAPK1HSD17B10ALDH1A1CYP3A4
Methylphenylsulfide SCHEMBL28196910 0.70 MAPT (0.47) KMT2AMEN1MAPTPOLBTP53
Methane SCHEMBL10582765 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5574024-A Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism EBETINO FRANK H (US) 1996-11-12 US disclosed
EP-0298553-B1 METHYLENE PHOSPHONOALKYLPHOSPHINATES, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM Norwich Eaton Pharmaceuticals, Inc. (US) 1992-01-15 EP disclosed
EP-0298553-A1 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism Norwich Eaton Pharmaceuticals, Inc. (US) 1989-01-11 EP disclosed